In recent years, mutations in DDX3X have been reported to be involved in chronic lymphocytic leukaemia (CLL), an incurable disease with variable clinical presentation and evolution [106–108, 139]. The gene discussed is DDX3X; the disease is B-cell chronic lymphocytic leukemia.